Summary by Moomoo AI
On November 4, 2024, Fosun Pharma (Group) Co., Ltd. in Shanghai submitted the latest Monthly Securities Variation Report to the Hong Kong Exchanges and Clearing Limited, covering data up to October 31, 2024. The report indicates that the listed statutory/registered share capital and outstanding number of H shares (stock code 02196) of the company on the Hong Kong Stock Exchange remained unchanged, with a balance of 551,940,500 shares. However, the A shares (stock code 600196) experienced changes this month, with the outstanding shares decreasing by 1,072,246 shares, resulting in a balance of 2,119,385,965 shares. This change was due to the cancellation of the relevant shares on October 8, 2024, in accordance with the Restricted A Shares Incentive Plan approved at the shareholders' meeting on November 29, 2022. The report did not mention commitments to issue, convertible bonds, other agreements or arrangements, as well as related information on Hong Kong Depositary Receipts.
